Anders Fink-Jensen
18PUBLICATIONS
60CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (18)
Sort by Publication Date:
|Jan 27, 2026
Phosphatidylethanol as an objective measure of heavy drinking days in a clinical trial for alcohol use disorder.Mathias E Jensen, Mette K Klausen, Marianne L Bergmann
|Jul 09, 2025
Effect of the GLP-1 receptor agonist exenatide on pro-inflammatory and metabolic biomarkers in individuals with alcohol use disorder: Post hoc results from a randomized, double-blinded, placebo-controlled clinical trial.Malthe E B Hviid, Lea A N Christoffersen, Mette K Klausen
|Mar 24, 2025
Blood phosphatidylethanol measurements indicate GLP-1 receptor stimulation causes delayed decreases in alcohol consumption.Mathias E Jensen, Mette K Klausen, Marianne L Bergmann
|Feb 01, 2025
Effects of GLP-1 Receptor Agonists in Alcohol Use Disorder.Mette Kruse Klausen, Gitte Moos Knudsen, Tina Vilsbøll
|Nov 14, 2024
Letter to the Editor Concerning "Glucagon-Like Peptide Agonists for Weight Management in Antipsychotic-Induced Weight Gain: A Systematic Review and Meta-Analysis".Anders Fink-Jensen, Christoph U Correll
|Nov 08, 2024
How to treat antipsychotic-related weight gain and metabolic disturbances: Is there a role for GLP-1 receptor agonists?Anders Fink-Jensen, Christoph U Correll
Pageof 3
Frequent Collaborators
4 joint publications
Mette Kruse Klausen
4 joint publications
Tina Vilsbøll
3 joint publications
Gitta Wörtwein
3 joint publications
Mathias E Jensen
2 joint publications
Morgane Thomsen
2 joint publications
Christoph U Correll
1 joint publications
Randy J Seeley
1 joint publications
Christos Pantelis
1 joint publications
Jens Richardt Møllegaard Jepsen
1 joint publications
Egill Rostrup
